Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Human Antibodies for Viral Infections
James E. Crowe
Annual Review of Immunology (2022) Vol. 40, Iss. 1, pp. 349-386
Closed Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies
Timothée Bruel, Jérôme Hadjadj, Piet Maes, et al.
Nature Medicine (2022) Vol. 28, Iss. 6, pp. 1297-1302
Open Access | Times Cited: 290
Antibodies to combat viral infections: development strategies and progress
Giuseppe Pantaleo, Bruno E. Correia, Craig Fenwick, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 9, pp. 676-696
Open Access | Times Cited: 158
Machine-designed biotherapeutics: opportunities, feasibility and advantages of deep learning in computational antibody discovery
Wiktoria Wilman, Sonia Wróbel, Weronika Bielska, et al.
Briefings in Bioinformatics (2022) Vol. 23, Iss. 4
Open Access | Times Cited: 60
A lung-selective delivery of mRNA encoding broadly neutralizing antibody against SARS-CoV-2 infection
Wanbo Tai, Kai Yang, Yubin Liu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 23
Sotrovimab to prevent severe COVID-19 in high-risk patients infected with Omicron BA.2
Guillaume Martin‐Blondel, Anne‐Geneviève Marcelin, Cathia Soulié, et al.
Journal of Infection (2022) Vol. 85, Iss. 4, pp. e104-e108
Open Access | Times Cited: 38
A research and development (R&D) roadmap for broadly protective coronavirus vaccines: A pandemic preparedness strategy
Penny L. Moore, T. Leighton, Julie Ostrowsky, et al.
Vaccine (2023) Vol. 41, Iss. 13, pp. 2101-2112
Open Access | Times Cited: 20
Hydrogen deuterium exchange and other mass spectrometry- based approaches for epitope mapping
Prashant N. Jethva, Michael L. Gross
Frontiers in Analytical Science (2023) Vol. 3
Open Access | Times Cited: 18
Rapid discovery of monoclonal antibodies by microfluidics-enabled FACS of single pathogen-specific antibody-secreting cells
Katrin Fischer, Aleksei Lulla, Tsz Y. So, et al.
Nature Biotechnology (2024)
Open Access | Times Cited: 6
Standing the test of COVID-19: charting the new frontiers of medicine
Simon Cauchemez, Giulio Cossu, Nathalie M. Delzenne, et al.
Frontiers in Science (2024) Vol. 2
Open Access | Times Cited: 6
Serum neutralization of SARS‐CoV‐2 Omicron BA.2, BA.2.75, BA.2.76, BA.5, BF.7, BQ.1.1 and XBB.1.5 in individuals receiving Evusheld
Qianqian Zhao, Xin Wang, Ze Zhang, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 7
Open Access | Times Cited: 13
Antiviral Approach to Cytomegalovirus Infection: An Overview of Conventional and Novel Strategies
Paolo Bottino, Lisa Pastrone, Antonio Curtoni, et al.
Microorganisms (2023) Vol. 11, Iss. 10, pp. 2372-2372
Open Access | Times Cited: 11
Expanding Differential Ion Mobility Separations into the MegaDalton Range
Tobias P. Wörner, Hayden A. Thurman, Alexander Makarov, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 14, pp. 5392-5398
Closed Access | Times Cited: 4
Revolutionizing antiviral therapy with nanobodies: Generation and prospects
Mujahed I. Mustafa, Ahmed Mohammed
Biotechnology Reports (2023) Vol. 39, pp. e00803-e00803
Open Access | Times Cited: 10
Chemoenzymatic liquid-phase synthesis and immunogenic assessment of tumor-associated complex MUC1 glycopeptide variants
Changcai Teng, Wenjing Ma, Jinfeng Liu, et al.
International Journal of Biological Macromolecules (2025) Vol. 302, pp. 140525-140525
Closed Access
Neutralizing human monoclonal antibodies that target the PcrV component of the Type III Secretion System of Pseudomonas aeruginosa act through distinct mechanisms
Jean-Mathieu Desveaux, Éric Faudry, Carlos Contreras‐Martel, et al.
(2025)
Open Access
Neutralizing human monoclonal antibodies that target the PcrV component of the Type III Secretion System of Pseudomonas aeruginosa act through distinct mechanisms
Jean-Mathieu Desveaux, Éric Faudry, Carlos Contreras‐Martel, et al.
(2025)
Open Access
Therapeutic treatment of hepatitis E virus infection in pigs with a neutralizing monoclonal antibody
Isabella Hrabal, Elmira Aliabadi, Sven Reiche, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Monoclonal Antibodies for Pediatric Viral Disease Prevention and Treatment
Zeynep BAHADIR, Priyanka Narayan, Rachael M. Wolters, et al.
PEDIATRICS (2025)
Closed Access
Structural basis for hepatitis E virus neutralization by potent human antibodies
Luis M. Molinos‐Albert, Eduard Baquero, Cyril Planchais, et al.
Science Advances (2025) Vol. 11, Iss. 19
Closed Access
Vaccinal effect of HIV-1 antibody therapy: dream or reality?
Mar Naranjo‐Gómez, Mireia Pelegrín
Current Opinion in HIV and AIDS (2023) Vol. 18, Iss. 4, pp. 209-216
Closed Access | Times Cited: 9
Pandemic preparedness strategies must go beyond vaccines
Rajesh Gupta, Lisa A. Purcell, Davide Corti, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 690
Closed Access | Times Cited: 8
Two antibodies show broad, synergistic neutralization against SARS-CoV-2 variants by inducing conformational change within the RBD
Hui Sun, Tingting Deng, Yali Zhang, et al.
Protein & Cell (2023) Vol. 15, Iss. 2, pp. 121-134
Open Access | Times Cited: 7
Development of Therapeutic Monoclonal Antibodies for Emerging Arbovirus Infections
Leonardo Fontoura Ormundo, Carolina Thome Barreto, Lilian Rumi Tsuruta
Viruses (2023) Vol. 15, Iss. 11, pp. 2177-2177
Open Access | Times Cited: 7
A Prototype-Pathogen Approach for the Development of Flavivirus Countermeasures
Richard Kühn, Alan D.T. Barrett, Aravinda M. deSilva, et al.
The Journal of Infectious Diseases (2023) Vol. 228, Iss. Supplement_6, pp. S398-S413
Closed Access | Times Cited: 5
Independent Analysis of the Results of the First Infant Immunization Campaign with Beyfortus® (Nirsevimab, Monoclonal Antibody against RSV, Bronchiolitis Virus): Mixed Results, Identification of Biases and Possible Role and Mechanisms of ADE (Antibod
Hélène Banoun
(2024)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top